About LYNZA

Lynza is an oral tyrosine kinase inhibitor used in the treatment of thyroid cancer, liver cancer, and renal cell carcinoma. By targeting multiple pathways involved in tumor angiogenesis and proliferation, Lynza helps control tumor growth and spread. Its multi-kinase inhibition makes it effective against difficult-to-treat solid tumors, and it is often employed in advanced cancer therapy.